Intuitive Intelligence
MARCH 26, 2024
In life, our purpose often hides in our experiences. Our journey to discovering our purpose can feel like a tough ride through the highs and lows of life. But within these ups and downs lies the true discovery of who we are and what drives us. Trials and Tribulations Reflecting on my own journey for purpose, I realize it’s a journey rooted in my upbringing and the trials I faced.
Oasis Family Medicine
MARCH 26, 2024
I recently had the privilege of joining Dr. Joy Kong on her podcast, Episode 65: Introducing EBOO. During our conversation, I discussed how EBOO (Extracorporeal Blood Oxygenation & Ozonation) has become quite a popular treatment in the holistic health and biohacking community. Based on my extensive experience, research, and studies conducted with EBOO therapy, we explored what this therapy can do for the body, the difference between EBOO and traditional ozone therapy (MAH - Major Autohemathe
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Evergreen Family Medicine
MARCH 29, 2024
It’s called “the green journal.” When I was in medical school in the 1970’s, it was the source most frequently quoted by faculty at OHSU. The American Journal of Medicine is the official journal of the Alliance for Academic Internal Medicine, a prestigious group of internal medicine department chairs at the top 125 medical schools across the U.S. In addition to its academic rigor, one of its primary stated aims is to enhance knowledge and improve effectiveness of public health interventions.
Logansport Memorial Hospital
MARCH 26, 2024
The total solar eclipse on April 8, 2024, will cast much of Indiana in a state of total darkness. Excitement is building across the state, and the state is expecting to see over anywhere from 145,000 to 581,000 out-of-state visitors traveling to view this solar event. We want to ensure that you’re prepared to safely enjoy the eclipse. What is a solar eclipse?
FDA Law Blog
MARCH 29, 2024
By John W.M. Claud & Kalie E. Richardson — While Covid is in the rear view for most of us, FDA has had a tough time shaking off the effects of the pandemic on its inspection output. Inspections went down—way down—during the pandemic. In March 2020 , FDA temporarily postponed all foreign and domestic and routine surveillance facility inspections.
Oasis Family Medicine
MARCH 26, 2024
In this podcast hosted by Dr. Katie Carter, I had an awesome opportunity to collaborate with Dr. Mike Belkowski, Founder of BioLight, where we had an informative discussion on methylene blue and leucomethylene blue, as well as red light therapy. I did this podcast because Dr. Mike's products are best in class when it comes to these products. Please watch the podcast and then check out the BioLight products in our Store.
The Clinical Problem Solvers
MARCH 27, 2024
[link] Episode description Reza and Rabih discuss a case of a patient with whole body pain Student discount [link] IMG discount Use coupon code RLRIMG at check out [link]
Primary Care Digest brings together the best content for architecture professionals from the widest variety of industry thought leaders.
FDA Law Blog
MARCH 26, 2024
By Sara W. Koblitz — The FTC appears to be on a mission to cleanse the Orange Book of patents it deems improperly listed. For the second time in recent years, the FTC has filed an Amicus Brief explaining exactly which patents should not be in the Orange Book. Last time, back in 2022 , the FTC took on REMS patents, explaining in litigation between Jazz and Avadel that the listing of REMS patents in the Orange Book is anticompetitive; this time, the FTC is going after device patents.
GeriPal
MARCH 28, 2024
Summary Transcript Summary One marker of the distance we’ve traveled in palliative care is the blossoming evidence base for the field. Ten years ago we would have been hard pressed to find 3 clinical trial abstracts submitted to the annual meeting, much less high quality randomized trials with robust measures, sample sizes, and analytics plans. Well, as a kick off to this year’s first in-person State of the Science plenary, held in conjunction with the closing Saturday session of the AAHPM/HPNA
PEMBlog
MARCH 27, 2024
This episode will help you better prepare for and manage children with inborn errors of metabolism in the Emergency Department. Consider it a supplement to what you remember from Biochemistry and the instructions on the family’s laminated care plan sheet. My special guest podcaster, Emily Groopman, is an actual Pediatric Geneticist in training and we hope that you will find this episode useful.
FDA Law Blog
MARCH 26, 2024
By Charles G. Raver & James E. Valentine & Frank J. Sasinowski — On March 21st, FDA announced the approval of the first nonsteroidal therapy for the treatment of Duchenne Muscular Dystrophy (DMD) (FDA press release available here ). Duvyzat (givinostat), a histone deacetylase (HDAC) inhibitor developed by Italfarmaco, S.p.A., represents a new class of therapeutics to slow progression of DMD and adds significantly to the armamentarium available to treat this relentlessly progressive and d
FDA Law Blog
MARCH 24, 2024
By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. The 340B contract pharmacy dispute involves several manufacturers who are refusing to provide 340B discounts to covered entities if they requested 340B drugs to be delivered to, and dispensed from, a network of contract p
Expert insights. Personalized for you.
130 
Let's personalize your content